CHEMOMAB THERAPEUTICS LTD (CMMB)
US16385C1045 - ADR
CHEMOMAB THERAPEUTICS LTD
NASDAQ:CMMB (1/14/2025, 8:00:01 PM)
After market: 1.87 -0.03 (-1.58%)1.9
-0.08 (-4.04%)
Company Profile
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Company Info
CHEMOMAB THERAPEUTICS LTD
Kiryat Atidim, Building 7
TEL AVIV-YAFO 02139
P: 972773310156
CEO: Neil Cohen
Employees: 20
Website: https://www.chemomab.com/
CMMB News
a month ago - Chemomab TherapeuticsChemomab to Participate in Oppenheimer’s Movers in Rare Disease Summita month ago - Chemomab TherapeuticsChemomab to Participate in Oppenheimer’s Movers in Rare Disease SummitChemomab management is participating in the Oppenheimer Movers in Rare Disease Summit on Dec 13, 2024 at the Westin Grand Central in NYC....
2 months ago - Chemomab TherapeuticsOral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis2 months ago - Chemomab TherapeuticsOral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing CholangitisOral presentation at AASLD highlights broad clinical activity of Chemomab’s CM-101 across multiple biomarkers and its disease-modifying potential in PSC...
2 months ago - Chemomab TherapeuticsChemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update3 months ago - Chemomab TherapeuticsChemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business UpdateCMMB Twits
Here you can normally see the latest stock twits on CMMB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
